ChEMBL

There are a comparatively large number of Chinese company invented drug entering clinical trials now - these are typically assigned USAN/INN looky-likey names, and seem to obey stem naming conventions. Does anyone know how these are assigned, is there an equivalent of USAN in China, where does the data get published, etc.?

As specific examples of these, there are a set of kinase inhibitors - Epitinib (EGFR), Flumatinib (ABL1), Fruquintinib (VEGFR), Icotinib (EGFR), Sulfatinib (VEGFR FGFR), Volitnib (MET).

I've also asked this question on Quora - I'll post any replies there in the comments section here.

Update: To be clear, I have no interest in the commercial import/export of drug substances into or out of China, I'm only interested in the name assignment process.